Abraxane NPs (albumin-based NP formulation of paclitaxel) conjugated with different tumor-homing peptides that selectively recognize tumor blood vessels or tumor lymphatics were tested for targeting cancer cells in mice with breast tumors. Here, ALB is linked to neoplasm.